BioCentury
ARTICLE | Clinical News

Eprotirome: Phase III started

September 26, 2011 7:00 AM UTC

Karo Bio began a double-blind, placebo-controlled, international Phase III trial to evaluate eprotirome daily in 630 patients for 2 years. Alkem Laboratories Ltd. (Mumbai, India) has exclusive rights...